According to Cognitive Market Research, the global adjuvant therapy market size was USD 2642.2 million in 2024. It will expand at a compound annual growth rate (CAGR) of 14.20% from 2024 to 2031.
North America held the major market share for more than 40% of the global revenue with a market size of USD 1056.88 million in 2024 and will grow at a compound annual growth rate (CAGR) of 12.4% from 2024 to 2031.
Europe accounted for a market share of over 30% of the global revenue with a market size of USD 792.66 million.
Asia Pacific held a market share of around 23% of the global revenue with a market size of USD 607.71 million in 2024 and will grow at a compound annual growth rate (CAGR) of 16.2% from 2024 to 2031.
Latin America had a market share of more than 5% of the global revenue with a market size of USD 132.11 million in 2024 and will grow at a compound annual growth rate (CAGR) of 13.6% from 2024 to 2031.
Middle East and Africa had a market share of around 2% of the global revenue and was estimated at a market size of USD 52.84 million in 2024 and will grow at a compound annual growth rate (CAGR) of 13.9% from 2024 to 2031.
The breast cancer category is the fastest-growing segment of the adjuvant therapy industry.
